Stay updated on Immunotherapy with TIL in Metastatic Melanoma Clinical Trial

Sign up to get notified when there's something new on the Immunotherapy with TIL in Metastatic Melanoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Immunotherapy with TIL in Metastatic Melanoma Clinical Trial page

  1. Check
    2 days ago
    No Change Detected
  2. Check
    9 days ago
    Change Detected
    Summary
    The ClinicalTrials.gov record for the metastatic melanoma immunotherapy study is displayed, with study details, participant eligibility, treatment arms, and reported outcomes.
    Difference
    89%
    Check dated 2026-11-07T11:30:33.000Z thumbnail image
  3. Check
    16 days ago
    Change Detected
    Summary
    The footer now identifies the site as revision v3.8.0 instead of v3.7.2.
    Difference
    0.2%
    Check dated 2026-10-31T11:08:47.000Z thumbnail image
  4. Check
    23 days ago
    Change Detected
    Summary
    A notice about NIH’s terminology transition from “Artificial Intelligence” to “Super Intelligence” appears above the ClinicalTrials.gov page. The study record remains unavailable behind a 403 error.
    Difference
    1%
    Check dated 2026-10-24T12:10:55.000Z thumbnail image
  5. Check
    30 days ago
    Change Detected
    Summary
    The footer revision identifier changed from v3.7.1 to v3.7.2.
    Difference
    0.2%
    Check dated 2026-10-17T13:19:20.000Z thumbnail image
  6. Check
    37 days ago
    Change Detected
    Summary
    The site footer revision changed from v3.7.0 to v3.7.1; the page continues to display a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-10T12:42:46.000Z thumbnail image
  7. Check
    58 days ago
    Change Detected
    Summary
    A new revision tag, Revision: v3.7.0, was added. Several core study documents and links, including the Informed Consent Form, Study Protocol and SAP, IPD sharing information, and publications, were removed from the record, reducing access to key materials and study context.
    Difference
    24%
    Check dated 2026-09-19T17:56:48.000Z thumbnail image

Stay in the know with updates to Immunotherapy with TIL in Metastatic Melanoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Immunotherapy with TIL in Metastatic Melanoma Clinical Trial page.